Atlas Trials

In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis

Clinical trial NCT01927120 · COMPLETED

Trial details

NCT number
NCT01927120
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Graft-Versus-Host-Disease
Start date
2014-03-25
Primary completion
2016-08-25
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.